Second, existing research using extensive national US cohorts underscores a notable trend: approximately 80% of clinical encounters do not involve the use of these biomarkers for this purpose, suggesting a prevailing clinical practice pattern that often omits ESR and CRP in the bacteremia diagnostic process in the US [ 28 ].
← all excerpts
Procalcitonin and Risk Prediction for Diagnosing Bacteremia in Hospitalized Patients: A Retrospective, National Observational Study.
1
—
—